{"data":{"id":"us-in/ic-27-8-14.3-8","jurisdiction":"us-in","citation":"IC 27-8-14.3-8","heading":"\"Nationally recognized clinical practice guidelines\"","body":"Sec. 8. As used in this chapter, \"nationally recognized clinical practice guidelines\" means evidence based clinical practice guidelines that:\n(1) are developed by an independent organization or medical professional society that:\n(A) uses a transparent methodology and reporting structure; and\n(B) has a conflict of interest policy;\n(2) establish standards of care informed by:\n(A) a systematic review of evidence; and\n(B) an assessment of the benefits and risks of alternative care options; and\n(3) include recommendations intended to optimize patient care.","path":["TITLE 27. INSURANCE","ARTICLE 8. LIFE, ACCIDENT, AND HEALTH","Chapter 14.3. Coverage for Biomarker Testing"],"source_url":"https://iga.in.gov/ic/2026/Title_27.html#27-8-14.3-8","current_through":"2026","vintage":"2026","retrieved_at":"2026-09-25T05:39:04Z","sha256":"8ee6efa4614f1fb63016855944eeaceeae750460ed29fb60159eb7f11f9e1c72","source_id":"us-in","stale":false,"prev":"us-in/ic-27-8-14.3-7","next":"us-in/ic-27-8-14.3-9"},"notice":"GroundRules: Original legal text. Not legal advice."}